| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Implantica AG (ST: IMP-A-SDB)
IMP-A-SDB Technical Analysis
2
| As on 26th Feb 2026 IMP-A-SDB STOCK Price closed @ 46.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 46.82 & Strong Buy for SHORT-TERM with Stoploss of 37.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMP-A-SDBSTOCK Price
| Open | 48.45 | Change | Price | % |
| High | 48.95 | 1 Day | -2.95 | -6.03 |
| Low | 43.60 | 1 Week | -0.35 | -0.76 |
| Close | 46.00 | 1 Month | -5.70 | -11.03 |
| Volume | 43784 | 1 Year | 9.25 | 25.17 |
| 52 Week High 83.00 | 52 Week Low 25.70 | ||||
ST Sweden Most Active Stocks
| QUIA | 0.00 | % |
| LIPI | 0.22 | -4.35% |
| IMMNOV | 0.25 | 38.89% |
| ACTI | 0.05 | 0.00% |
| SBB-B | 4.06 | 4.37% |
| SOLT | 0.11 | 0.00% |
| EPIS-B | 0.04 | 0.00% |
| LUNE | 21.97 | 6.65% |
| NIBE-B | 36.41 | 3.73% |
| POLY | 0.04 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| IMP-A-SDB Daily Charts |
IMP-A-SDB Intraday Charts |
Whats New @ Bazaartrend |
IMP-A-SDB Free Analysis |
|
|
IMP-A-SDB Important Levels Intraday
| RESISTANCE | 56.31 |
| RESISTANCE | 53.00 |
| RESISTANCE | 50.96 |
| RESISTANCE | 48.92 |
| SUPPORT | 43.08 |
| SUPPORT | 41.04 |
| SUPPORT | 39.00 |
| SUPPORT | 35.69 |
IMP-A-SDB Forecast February 2026
| 4th UP Forecast | 67.1 |
| 3rd UP Forecast | 60.33 |
| 2nd UP Forecast | 56.15 |
| 1st UP Forecast | 51.97 |
| 1st DOWN Forecast | 40.03 |
| 2nd DOWN Forecast | 35.85 |
| 3rd DOWN Forecast | 31.67 |
| 4th DOWN Forecast | 24.9 |
IMP-A-SDB Weekly Forecast
| 4th UP Forecast | 52.74 |
| 3rd UP Forecast | 50.58 |
| 2nd UP Forecast | 49.24 |
| 1st UP Forecast | 47.91 |
| 1st DOWN Forecast | 44.09 |
| 2nd DOWN Forecast | 42.76 |
| 3rd DOWN Forecast | 41.42 |
| 4th DOWN Forecast | 39.26 |
IMP-A-SDB Forecast2026
| 4th UP Forecast | 170.1 |
| 3rd UP Forecast | 130.3 |
| 2nd UP Forecast | 105.7 |
| 1st UP Forecast | 81.1 |
| 1st DOWN Forecast | 10.9 |
| 2nd DOWN Forecast | -13.7 |
| 3rd DOWN Forecast | -38.3 |
| 4th DOWN Forecast | -78.1 |
Implantica AG ( ST Sweden Symbol : IMP-A-SDB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMP-A-SDB Business Profile
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; AppetiteControl, an implant to treat obesity by controlling appetite; and UriControl, a remote controlled implant to treat urinary incontinence for men and women. The company was founded in 2015 and is based in Vaduz, Liechtenstein. Implantica AG is a subsidiary of Implantica MediSwiss. Address: Landstrasse 1, Vaduz, Liechtenstein, 9490
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service